Neurological Manifestations in Primary Sjögren's Syndrome: A Comparative Review of Inflammatory Mechanisms

被引:0
作者
Moradi, Fatemeh [1 ]
Shafiei, Golnaz [2 ]
Shahrzad, Maryam [3 ]
Mokhtari, Tahmineh [4 ,5 ]
机构
[1] Univ Arkansas Med Sci UAMS, Dept Physiol & Cell Biol, Dole lab, Little Rock, AR USA
[2] Kashan Univ Med Sci, Inst Basic Sci, Anat Sci Res Ctr, Kashan, Iran
[3] Univ Calif Davis, Med Ctr, Dept Radiol, Div Neuroradiol, Sacramento, CA 95616 USA
[4] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA
[5] Univ Calif Davis, UCD Comprehens Canc Ctr, Davis, CA 95616 USA
关键词
Primary Sj & ouml; gren's syndrome; central nervous system; neuroinflammatory diseases; pathology; NERVOUS-SYSTEM INVOLVEMENT; PRIMARY SJOGRENS-SYNDROME; INTRAVENOUS IMMUNOGLOBULIN TREATMENT; PAINFUL SENSORY NEUROPATHY; DORSAL-ROOT GANGLIONITIS; CLINICAL-MANIFESTATIONS; LIMBIC ENCEPHALITIS; AUTOIMMUNE-DISEASES; CEREBELLAR-ATAXIA; PLASMA-EXCHANGE;
D O I
10.22317/jcms.v11i2.1781
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Primary Sj & ouml;gren's syndrome (pSS) is a systemic autoimmune disorder marked by chronic inflammation, with neurological involvement often overlooked. This review highlights the inflammation-driven mechanisms underlying both peripheral and central nervous system (PNS, CNS) manifestations of pSS. PNS complications, particularly axonal sensorimotor and pure sensory neuropathies, are more common than CNS involvement. CNS abnormalities include diffuse white matter lesions and hippocampal atrophy. Immune dysregulation plays a central role, with emerging evidence implicating NLRP3 inflammasome activation and vasculitic processes. Aberrant B-cell activity may lead to pathogenic autoantibody production and direct neural injury. Infiltration ofT-and B-cells into neural tissues, facilitated byastrocyte-mediated disruption of the blood-brain barrier, promotes cytokine-driven neuroinflammation. These processes contribute to cognitive, sensory, and motor dysfunction in pSS. Although conventional and biological therapies show promise, robust clinical trials are lacking. Understanding the immunopathogenesis of pSS may pave the way for targeted interventions. This review synthesizes current findings on neuroinflammatory mechanisms in pSS and their clinical implications.
引用
收藏
页码:86 / 97
页数:12
相关论文
共 147 条
[1]   CNS demyelinating events in primary Sjogren's syndrome: A single-center case series on the clinical phenotype [J].
Afzali, Ali M. ;
Moog, Philipp ;
Kalluri, Sudhakar Reddy ;
Hofauer, Benedikt ;
Knopf, Andreas ;
Kirschke, Jan Stefan ;
Hemmer, Bernhard ;
Berthele, Achim .
FRONTIERS IN NEUROLOGY, 2023, 14
[2]   White matter abnormalities in primary Sjogren syndrome [J].
Akasbi, M. ;
Berenguer, J. ;
Saiz, A. ;
Brito-Zeron, P. ;
Perez-De-Lis, M. ;
Bove, A. ;
Diaz-Lagares, C. ;
Retamozo, S. ;
Blanco, Y. ;
Perez-Alvarez, R. ;
Bosch, X. ;
Siso, A. ;
Graus, F. ;
Ramos-Casals, M. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (05) :433-443
[3]   ANTI-RO(SS-A) AUTOANTIBODIES IN CENTRAL-NERVOUS-SYSTEM DISEASE-ASSOCIATED WITH SJOGRANS SYNDROME (CNS-SS) - CLINICAL, NEUROIMAGING, AND ANGIOGRAPHIC CORRELATES [J].
ALEXANDER, EL ;
RANZENBACH, MR ;
KUMAR, AJ ;
KOZACHUK, WE ;
ROSENBAUM, AE ;
PATRONAS, N ;
HARLEY, JB ;
REICHLIN, M .
NEUROLOGY, 1994, 44 (05) :899-908
[4]  
ALEXANDER EL, 1993, RHEUM DIS CLIN N AM, V19, P869
[5]   EVIDENCE OF AN IMMUNOPATHOGENIC BASIS FOR CENTRAL-NERVOUS-SYSTEM DISEASE IN PRIMARY SJOGRENS-SYNDROME [J].
ALEXANDER, EL ;
LIJEWSKI, JE ;
JERDAN, MS ;
ALEXANDER, GE .
ARTHRITIS AND RHEUMATISM, 1986, 29 (10) :1223-1231
[6]   SJOGREN SYNDROME - CENTRAL NERVOUS-SYSTEM MANIFESTATIONS [J].
ALEXANDER, GE ;
PROVOST, TT ;
STEVENS, MB ;
ALEXANDER, EL .
NEUROLOGY, 1981, 31 (11) :1391-1396
[7]  
Alunno A, 2019, CLIN EXP RHEUMATOL, V37, pS192
[8]   Common and rare forms of vasculitis associated with Sjogren's syndrome [J].
Argyropoulou, Ourania D. ;
Tzioufas, Athanasios G. .
CURRENT OPINION IN RHEUMATOLOGY, 2020, 32 (01) :21-28
[9]   D-penicillamine treatment for chronic sensory ataxic neuropathy associated with Sjogren's syndrome [J].
Asahina, M ;
Kuwabara, S ;
Asahina, M ;
Nakajima, M ;
Hattori, T .
NEUROLOGY, 1998, 51 (05) :1451-1453
[10]  
Bandler M, 2024, Annals of Internal Medicine: Clinical Cases, V3